Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Helix, St. Luke's University Health Network Partner on Population Health Study
The program initially aims to enroll 100,000 participants over four years, with consenting individuals receiving information about their potential risks for serious health conditions.
Senators Reintroduce Bill to Establish Medicare Coverage Pathway for MCED Tests
The bill would allow Medicare to cover MCED tests following approval by FDA and ensure their use would not impact coverage of traditional screenings.
Nasopharyngeal Carcinoma Risk Genes Identified, Characterized
Using association, regulatory, and functional analyses coupled with cell line experiments, researchers characterized new nasopharyngeal cancer risk genes.
Exact Sciences Releases Next-Gen Cologuard Data, Inks New Partnerships
The firm said the new version of its colon cancer screening test improved upon its predecessor across a variety of metrics, including both sensitivity and specificity.
FDA Launches Pilot Program to Determine Performance Criteria for Lab-Developed CDx Tests
Through the voluntary program, the agency will ask drug manufacturers for performance information for the tests used to enroll patients in pharmaceutical clinical trials.